The program can collectively award a total of up to US$1 million in grants over a two-year period

The PHAB Awards aim to support clinical research in pulmonary hypertension (PH) with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Applicants may include early-mid career investigators, fellows in training, and other PH healthcare professionals working in the USA. The objectives of the program are to:

  • Support continued advancement in PH science and care
  • Contribute to the continued growth of early-career scientists and clinicians involved in PH research
  • Build lasting relationships within the research community and promote collaboration between awardees, past and present